Seller record · prescribedrx.com
PrescribedRX
Fails 3 of 8 criteria. S2, prescription gating: The sermorelin, NAD+ and glutathione buttons open a guest checkout that takes payment, at $199.00 for sermorelin, with no health question before the place order button, and the purchase terms refund the order only if a provider later declines. The GLP-1 path opens a 16-step eligibility quiz first. 2 more criteria also fail; see the table below.
At a glance
PrescribedRXprescribedrx.com
- Price
- Sermorelin $199 a month (sale; regular $249)
- Sells
- compounded semaglutide, compounded tirzepatide, sermorelin, and 5 more
- FDA letters
- None on file
Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.
A telehealth platform selling compounded semaglutide and tirzepatide plans and sermorelin, NAD+ and glutathione plans, prescribed by clinicians of the Telegra MD network. Its peptide plans open a payment checkout before any health question, and the site names no filling pharmacy.
Operating entity PrescribedRx, LLC
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | prescribedrx.com/plans, prescribedrx.com/about |
| S2 | Prescription gating | FAIL | prescribedrx.com/checkouts/sermorelin-injection-1-month, join.prescribedrx.com/weight-loss, prescribedrx.com/purchase-terms |
| S3 | Pharmacy identification | FAIL | prescribedrx.com/plans, prescribedrx.com/about, prescribedrx.com/purchase-terms |
| S4 | Compounding disclosure | PASS | prescribedrx.com/plans/injectable-semaglutide, prescribedrx.com/plans/sermorelin-injections |
| S5 | Analytical documentation | FAIL | prescribedrx.com/plans, prescribedrx.com/longevity-safety-information |
| S6 | Business address | PASS | prescribedrx.com/about, prescribedrx.com/privacy-policy |
| S7 | Price disclosure | PASS | prescribedrx.com/plans/sermorelin-injections, prescribedrx.com/plans/nad-plus-injections, prescribedrx.com/plans/injectable-tirzepatide, prescribedrx.com/plans/injectable-semaglutide |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+ injection and nasal spray, glutathione injection and nasal spray, testosterone and enclomiphene, erectile dysfunction tablets, hair loss chewable.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathione
Unpaid link. PrescribedRX does not pay the site, and nothing is earned when it is used. Funding.
Visit PrescribedRXDispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.